BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FOXP1
,
nitric oxide metabolic process
,
Influenza
,
Stem cell
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vemurafenib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SPRY4
DUSP6
UCN2
ETV4
SPRY2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
DODD_NASOPHARYNGEAL_CARCINOMA_DN
FISCHER_DREAM_TARGETS
PUJANA_CHEK2_PCC_NETWORK
BERENJENO_TRANSFORMED_BY_RHOA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Malignant melanoma COLO829 cells depleted of MITF and/or treated with vemurafenib
Melanoma A375 cells treated with the BRAFV600E inhibitor vemurafenib
Melanoma Melmet5 cells monocultured or cocultured with lung fibroblasts and treated with vemurafenib
Cutaneous squammous cell carcinoma B9 cells with HRAS-Q61L treated with RAF inhibitors
Malignant melanoma A375 cells treated with BRAF inhibitor vemurafenib
Explore Curated Studies Results
Literature
Most Relevant Literature
A Quality by Design Approach for Developing SNEDDS Loaded with Vemurafenib for Enhanced Oral Bioavai…
Dynamic transcriptome analysis reveals signatures of paradoxical effect of vemurafenib on human derm…
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Pat…
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Vemurafenib, Carboplatin, and Paclitaxel
A Study of Vemurafenib in Participants With Metastatic Melanoma
ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ